Hassan M. Shaleh

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Yu Wang, Xiwei Ding, Shaoqing Wang et al. · Cancer Letters · 2016 · 86 citations

Medicine, Oncology, Pharmacology +17

Transcriptional Induction of Periostin by a Sulfatase 2–TGFβ1–SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma

Gang Chen, Ikuo Nakamura, Renumathy Dhanasekaran et al. · Cancer Research · 2016 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +17

Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

Ikuo Nakamura, Kais Zakharia, Bubu A. Banini et al. · PLoS ONE · 2014 · 61 citations · Full text

Life Sciences, Molecular Medicine, Pharmacology +17

Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells

Xiwei Ding, Roongruedee Chaiteerakij, Catherine D. Moser et al. · Oncotarget · 2016 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Knowledge, Attitudes, and Behaviors of Viral Hepatitis Among Recent African Immigrants in the United States: A Community Based Participatory Research Qualitative Study

Essa A. Mohamed, Nasra H. Giama, Hassan M. Shaleh et al. · Frontiers in Public Health · 2020 · 28 citations · Full text

Public Health, Community Health, Preventive Medicine +17